Properties (95)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:brand |
high.
|
| gptkbp:customerFeedback |
positive.
|
| gptkbp:hasAbstract |
This patent describes a method for treating a specific disease using a novel compound.
|
| gptkbp:hasActivities |
anti-inflammatory
|
| gptkbp:hasAffiliation |
with drug A.
|
| gptkbp:hasApplicationNumber |
10/123,456
PCT/US2003/012345 |
| gptkbp:hasAssignee |
Company XYZ
|
| gptkbp:hasCharacter |
excellent.
|
| gptkbp:hasCitations |
US_5,678,901.
|
| gptkbp:hasClaim |
20 claims
|
| gptkbp:hasCollaborationsWith |
with University B.
with_Institute_C. |
| gptkbp:hasCompetitors |
unique formulation.
Competitor D. |
| gptkbp:hasContribution |
global.
rapid. targeted. |
| gptkbp:hasCountry |
gptkb:United_States
|
| gptkbp:hasCPCClassification |
C07D 401/12
|
| gptkbp:hasDescription |
The invention relates to a method for treating a disease.
|
| gptkbp:hasEquipment |
better efficacy.
disease X. |
| gptkbp:hasEvents |
mandatory.
|
| gptkbp:hasExaminer |
Jane_Smith
|
| gptkbp:hasFacility |
Family A.
|
| gptkbp:hasFeature |
ongoing.
favorable. promising. 70% response rate. |
| gptkbp:hasFieldOfUse |
pharmaceuticals
|
| gptkbp:hasFilingDate |
2004-02-06
|
| gptkbp:hasFilm |
nausea.
|
| gptkbp:hasFunding |
government grant.
|
| gptkbp:hasGoals |
efficient.
|
| gptkbp:hasHistory |
conducted.
|
| gptkbp:hasInventor |
gptkb:Alice_Johnson
gptkb:John_Doe |
| gptkbp:hasLabel |
clear instructions.
|
| gptkbp:hasLegalStatus |
Active
licensed. |
| gptkbp:hasLocalCuisine |
Phase II.
NCT01234567. |
| gptkbp:hasLocation |
leader.
|
| gptkbp:hasMerchandise |
inhibitor.
|
| gptkbp:hasOccupation |
strict.
met. FDA_approved. FDA. |
| gptkbp:hasPartnershipsWith |
numerous.
with Company E. |
| gptkbp:hasPatentNumber |
6,789,618
|
| gptkbp:hasPerformance |
ongoing.
|
| gptkbp:hasPerformedAt |
tablet.
|
| gptkbp:hasPopulation |
adults.
|
| gptkbp:hasPriorityDate |
2004-09-14
2003-02-06 2024-09-14 |
| gptkbp:hasPrograms |
available.
Low toxicity. |
| gptkbp:hasPublications |
2004-03-18
2004-0123456 A1 |
| gptkbp:hasRelatedPatent |
gptkb:US_6,789,619_C61
Utility Patent incremental innovation. US_6,789,620_C61 |
| gptkbp:hasResearchInterest |
biochemistry
pharmacology conducted. clinical trials. high citation rate. Journal_of_Medicinal_Chemistry. XYZ_Pharmaceuticals. NIH_grant. |
| gptkbp:hasSpecialty |
high.
patent portfolio. fast track. |
| gptkbp:hasStudentOrganizations |
C20H25N3O2
|
| gptkbp:hasTechnicalField |
medicinal chemistry
|
| gptkbp:hasTechnology |
successful.
Improved treatment efficacy. |
| gptkbp:hasTitle |
Method for treating a disease
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,618 C61
|
| gptkbp:isCitedBy |
gptkb:US_7,123,456_B2
|
| gptkbp:isFiledIn |
gptkb:United_States
|
| gptkbp:isMarketedAs |
wide distribution.
|
| gptkbp:isRelatedTo |
gptkb:US_6,123,456
|
| gptkbp:market |
significant.
available in multiple countries. 2025-01-01. commercialized. Chronic disease treatment. |
| gptkbp:provides |
oncology.
|
| gptkbp:route |
oral.
|